Nihon Kohden (OTCMKTS:NHNKY) Sees Large Volume Increase – Should You Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares saw strong trading volume on Wednesday . 187,851 shares changed hands during mid-day trading, an increase of 615% from the previous session’s volume of 26,287 shares.The stock last traded at $8.58 and had previously closed at $8.4425.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy”.

Nihon Kohden Trading Up 1.6%

The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 14.54 and a beta of 0.39. The company has a 50-day moving average of $9.22 and a 200-day moving average of $10.16.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. On average, research analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.